Medicinal Mushrooms in Cancer Support

Medicinal Mushrooms in Cancer Support

Complementary therapies are increasingly used by people diagnosed with cancer. Among these, medicinal mushroomshave attracted attention for their immune-modulating, anti-inflammatory and potential anti-tumour properties. While they offer promise in the integrative oncology setting, they must be used thoughtfully — ideally under the guidance of a qualified practitioner working in coordination with the medical oncology team — to ensure they support rather than interfere with conventional treatment.

What are medicinal mushrooms and how might they help?

“Mushrooms” in this context refers to certain fungi (often polypore or Basidiomycete species) processed into extracts, powders or capsules for therapeutic use. Some common examples include:

  • Trametes versicolor (Turkey Tail) – often its extract PSK (polysaccharide‐K) is studied.
  • Ganoderma lucidum (Reishi) – widely used in traditional Asian medicine and researched for immune & anti‐tumour effects.
  • Lentinula edodes (Shiitake) and Grifola frondosa (Maitake) – also used for immune support in cancer contexts.

Research suggests these mushrooms may help in several ways:

  • Immune modulation: enhancing activity of natural killer cells, supporting dendritic and other innate immune cells.
  • Reducing side-effects of conventional therapies: some studies report improved quality of life or lower treatment toxicity when mushrooms are used alongside chemo/radiation.
  • Possible direct anti-tumour effects in laboratory settings: e.g., inducing apoptosis (cell death), inhibiting angiogenesis or modulating signalling pathways in tumour cells.

Why working with a practitioner matters

Given the complexity of cancer care, the use of medicinal mushrooms should be managed within an integrative framework with the following key components:

  1. Understanding the full treatment protocol
    A practitioner who supports cancer care needs to know which conventional therapies are being used (surgery, chemotherapy, radiation, immunotherapy, hormone therapy, etc), the timing, dosages, and any known side-effects. Without this context it’s impossible to safely integrate complimentary therapies such as mushrooms.
  2. Selecting the right mushroom extract, dosage and timing
    Not all mushroom products are equal. The bioactive compounds vary widely by species, preparation method, extraction technique and quality control. A practitioner can select products with credible evidence or appropriate traditional usage, and tailor dose/timing (for example, avoiding introduction of a new extract during a high-risk chemo period until ensuring stability).
  3. Supporting overall recovery and vitality
    Beyond acute treatment support, medicinal mushrooms can be part of a post-treatment recovery plan — helping rebuild immune resilience, reduce lingering side-effects (fatigue, reduced immunity, digestive issues), and promoting vitality and quality of life. A treatment plan ensures the mushrooms are part of a broader strategy (nutrition, lifestyle, rest/recovery, stress management) rather than a standalone “magic bullet.”
  4. Ensuring communication with the oncology team
    When a practitioner supports complementary medicine in cancer care, they should proactively communicate (with permission) with the patient’s oncologist, so that everyone is aligned and no surprises occur. This collaborative approach helps ensure safety, avoids duplication or conflict of care, and fosters trust.

Practical considerations & safety tips

Here are some practical guidelines for clinicians and patients considering medicinal mushrooms in the cancer journey:

  • Ensure you have clearance from your oncology team before starting any new supplement (including mushrooms).
  • Use high-quality, third-party tested mushroom extracts from reputable sources; avoid unverified “wild foraged” preparations with unknown potency or contamination.
  • Introduce any new supplement slowly, ideally after a period of stability in conventional therapy.
  • Monitor blood counts, liver & kidney function, immune markers, and coagulation parameters as relevant.
  • Be cautious if you have low platelets, are on anticoagulants, have autoimmune conditions or are undergoing immunotherapy — mushrooms modulate immunity and could theoretically alter immune responses.
  • Be clear that medicinal mushrooms are adjunctive, not a substitute for standard cancer treatments. They support the journey, but you still need full medical care.
  • Track your response: quality of life, side-effects, energy levels, immune resilience, not just tumour markers.
  • Let your integrative practitioner and oncology team know of all supplements, herbs, vitamins and mushrooms being taken — this prevents unanticipated interactions.

A balanced view

Medicinal mushrooms hold promise in oncology support — but they are not a cure on their own and must be used with care. The role of a knowledgeable integrative practitioner is to bridge the worlds of complementary and conventional care: selecting the right preparations, timing them appropriately, evaluating safety, monitoring outcomes, and liaising with medical specialists. With this collaborative model, the use of medicinal mushrooms can enhance treatment support, improve quality of life and aid recovery and vitality — while keeping safety front and centre.

Final thoughts

If you’re navigating a cancer diagnosis and considering medicinal mushrooms as part of your care, you don’t have to figure it out alone. Seek a practitioner experienced in oncology-supportive care, share your full treatment history, let them coordinate with your oncology team and design a safe, evidence-informed plan. Your conventional treatment remains the foundation — and mushrooms may be a meaningful, supportive layer on top.

References

  1. Jeitler M, Michalsen A, Frings D, Hübner M, Fischer M, Koppold-Liebscher D, Murthy V, Kessler CS. Significance of Medicinal Mushrooms in Integrative Oncology: A Narrative Review. Frontiers in Pharmacology.2020;11:580656. (Frontiers)
  2. Narayanan S, de Mores AR, Cohen L, Moustapha A, Lazar F, Hicklen R, Lopez G, Yang P, Bruera E. Medicinal Mushroom Supplements in Cancer: A Systematic Review of Clinical Studies. Curr Oncol Rep. 2023;25(6):569-587. (SpringerLink)
  3. National Cancer Institute (NCI). Medicinal Mushrooms (PDQ®) – Health Professional Version. Updated 11 Jun 2024. (Cancer.gov)
  4. Górska-Jakubowska S, Wu Y, Turło J, Xu B. Critical Review on the Anti-Tumor Activity of Bioactive Compounds from Edible and Medicinal Mushrooms over the Last Five Years. Nutrients. 2025;17(11):1887. (MDPI)
  5. Meera M. Medicinal Mushrooms in Supportive Cancer Therapy: A Review. In: “Medicinal Mushrooms in Supportive Cancer Therapy.” Taylor & Francis; 2021. (Taylor & Francis)